Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Vaccinia 1Uterine Cervical Neoplasms 1Squamous Non-small Cell Lung Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma 1Neoplasms by Site 1Neoplasms by Histologic Type 1Melanoma 1Locally Advanced Pancreatic Cancer 1Gastric Adenocarcinoma 1Gallbladder Cancer Unresectable 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1Brain Neoplasms 1Anal Cancer Metastatic 1

Interventions

Cisplatin 11Specimen Handling 9Magnetic Resonance Spectroscopy 9pembrolizumab 6durvalumab 6Platinum 61,2-diaminocyclohexaneplatinum II citrate 6cemiplimab 5Carboplatin 5Radiation 4Cetuximab 4Biopsy 4poly ICLC 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Nivolumab 3Docetaxel 3(225)Ac-DOTA-c(RGDyK) 3ipatasertib 2cabozantinib 2atezolizumab 2Oxaliplatin 2Ipilimumab 2Immunoglobulin G 2Fluorouracil 2Disulfides 2Capecitabine 2ALT-803 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma × 130-nm albumin-bound paclitaxel × 30 days × Clear all
NCT06463665 2026-06-04

VIRO-25

Genelux Corporation

Phase 2 Recruiting
142 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

NCT07618793 2026-06-01

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Xuanwu Hospital, Beijing

Phase 2 Not yet recruiting
60 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡